Development of live cultural pandemic influenza vaccine Vector-Flu.
Elena A Nechaeva, Tatyana Y Sen'kina, Alexander B Ryzhikov, Irina F Radaeva, Ol'ga G P'yankova, Natal'ya V Danil'chenko, Tatyana M Sviridenko, Marina P Bogryantzeva, Natal'ya V Gilina, Nikolay A Varaksin, Tatyana G Ryabicheva, Irina V Kiseleva, Larisa G Rudenko
Author Information
- Elena A Nechaeva: Department of Cell Culture Technology, SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Tatyana Y Sen'kina: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Alexander B Ryzhikov: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Irina F Radaeva: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Ol'ga G P'yankova: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Natal'ya V Danil'chenko: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Tatyana M Sviridenko: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Marina P Bogryantzeva: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Natal'ya V Gilina: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Nikolay A Varaksin: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Tatyana G Ryabicheva: SRC VB VECTOR, Novosibirsk, 630559, Russia.
- Irina V Kiseleva: Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg, 197376, Russia.
- Larisa G Rudenko: Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg, 197376, Russia.
No abstract text available.
